279 related articles for article (PubMed ID: 11896294)
1. Prevention of vitamin A teratogenesis by phytol or phytanic acid results from reduced metabolism of retinol to the teratogenic metabolite, all-trans-retinoic acid.
Arnhold T; Elmazar MM; Nau H
Toxicol Sci; 2002 Apr; 66(2):274-82. PubMed ID: 11896294
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
Elmazar MM; Nau H
Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
[TBL] [Abstract][Full Text] [Related]
3. 4-Methylpyrazole partially ameliorated the teratogenicity of retinol and reduced the metabolic formation of all-trans-retinoic acid in the mouse.
Collins MD; Eckhoff C; Chahoud I; Bochert G; Nau H
Arch Toxicol; 1992; 66(9):652-9. PubMed ID: 1482289
[TBL] [Abstract][Full Text] [Related]
4. Derivation of retinoic acid and metabolites from a teratogenic dose of retinol (vitamin A) in mice.
Kochhar DM; Penner JD; Satre MA
Toxicol Appl Pharmacol; 1988 Dec; 96(3):429-41. PubMed ID: 3206525
[TBL] [Abstract][Full Text] [Related]
5. Transplacental pharmacokinetics and teratogenicity of a single dose of retinol (vitamin A) during organogenesis in the mouse.
Eckhoff C; Löfberg B; Chahoud I; Bochert G; Nau H
Toxicol Lett; 1989 Aug; 48(2):171-84. PubMed ID: 2772923
[TBL] [Abstract][Full Text] [Related]
6. Phytanic acid and docosahexaenoic acid increase the metabolism of all-trans-retinoic acid and CYP26 gene expression in intestinal cells.
Lampen A; Meyer S; Nau H
Biochim Biophys Acta; 2001 Oct; 1521(1-3):97-106. PubMed ID: 11690641
[TBL] [Abstract][Full Text] [Related]
7. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats.
Collins MD; Tzimas G; Hummler H; Bürgin H; Nau H
Toxicol Appl Pharmacol; 1994 Jul; 127(1):132-44. PubMed ID: 8048045
[TBL] [Abstract][Full Text] [Related]
8. Teratogenicity, tissue distribution, and metabolism of the retro-retinoids, 14-hydroxy-4,14-retro-retinol and anhydroretinol, in the C57BL/6J mouse.
Mao GE; Collins MD; Derguini F
Toxicol Appl Pharmacol; 2000 Feb; 163(1):38-49. PubMed ID: 10662603
[TBL] [Abstract][Full Text] [Related]
9. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
Elmazar MM; Reichert U; Shroot B; Nau H
Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
[TBL] [Abstract][Full Text] [Related]
10. Receptor-selective retinoid agonists and teratogenic activity.
Willhite CC; Dawson MI; Reichert U
Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
[TBL] [Abstract][Full Text] [Related]
11. Differential teratogenic response of mouse embryos to receptor selective analogs of retinoic acid.
Kochhar DM; Jiang H; Penner JD; Beard RL; ChandraratnaAS
Chem Biol Interact; 1996 Mar; 100(1):1-12. PubMed ID: 8599851
[TBL] [Abstract][Full Text] [Related]
12. Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentrations during organogenesis: comparison to the all-trans isomer.
Kraft JC; Kochhar DM; Scott WJ; Nau H
Toxicol Appl Pharmacol; 1987 Mar; 87(3):474-82. PubMed ID: 3470977
[TBL] [Abstract][Full Text] [Related]
13. Reduction of all-trans-retinoic acid-induced teratogenesis in the rat by glycine administration.
Martínez-Angoa A; Parra-Hernández E; Madrigal-Bujaidar E; Chamorro-Cevallos G; Carvajal-Sandoval G; Zamudio-Cortes P
Birth Defects Res A Clin Mol Teratol; 2006 Oct; 76(10):731-8. PubMed ID: 17022025
[TBL] [Abstract][Full Text] [Related]
14. Embryonic subcellular distribution of 13-cis- and all-trans-retinoic acid indicates differential cytosolic/nuclear localization.
Rühl R; Plum C; Elmazar MM; Nau H
Toxicol Sci; 2001 Sep; 63(1):82-9. PubMed ID: 11509747
[TBL] [Abstract][Full Text] [Related]
15. The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not of isomerization to all-trans-retinoic acid.
Tzimas G; Bürgin H; Collins MD; Hummler H; Nau H
Arch Toxicol; 1994; 68(2):119-28. PubMed ID: 8179481
[TBL] [Abstract][Full Text] [Related]
16. All-trans-retinoic acid in maternal plasma and teratogenicity in rats and rabbits.
Tembe EA; Honeywell R; Buss NE; Renwick AG
Toxicol Appl Pharmacol; 1996 Dec; 141(2):456-72. PubMed ID: 8975771
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic assessment of teratologically effective concentrations of an endogenous retinoic acid metabolite.
Satre MA; Penner JD; Kochhar DM
Teratology; 1989 Apr; 39(4):341-8. PubMed ID: 2749577
[TBL] [Abstract][Full Text] [Related]
18. Induction of RAR-beta 2 gene expression in embryos and RAR-beta 2 transactivation by the synthetic retinoid Ro 13-6307 correlates with its high teratogenic potency.
Soprano DR; Tairis N; Gyda M; Harnish DC; Jiang H; Soprano KJ; Kochhar DM
Toxicol Appl Pharmacol; 1993 Sep; 122(1):159-63. PubMed ID: 8397452
[TBL] [Abstract][Full Text] [Related]
19. Synergistic teratogenic effects induced by retinoids in mice by coadministration of a RARalpha- or RARgamma-selective agonist with a RXR-selective agonist.
Elmazar MM; Rühl R; Nau H
Toxicol Appl Pharmacol; 2001 Jan; 170(1):2-9. PubMed ID: 11141350
[TBL] [Abstract][Full Text] [Related]
20. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit.
Collins MD; Tzimas G; Bürgin H; Hummler H; Nau H
Toxicol Appl Pharmacol; 1995 Jan; 130(1):9-18. PubMed ID: 7839374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
